Priser
Platform
Blog
Om os
Download
Pro Medicus
Pro Medicus
Australian Securities Exchange
0

Om

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I PRO MEDICUS MED ENDAVU: Køb Pro Medicus ($PME) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Pro Medicus, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerPME
Land
Australien
Hjemmesidepromed.com.au
SektorSundhed
IndustriSundhedsinformationstjenester

Udbytter

0,11AUD
'19
0,12AUD
'20
0,15AUD
'21
0,22AUD
'22
0,3AUD
'23
0,4AUD
'24
Ex-udbytte-dato4. sep. 2024
Udbytteafkast0,15%

Analytikerskøn

Baseret på 14 analytikere

Stærkt købKøbHoldSælgStærkt sælg
7%14%64%14%0%